We have previously demonstrated that intratumoral injection of viral epitopes could redirect preexisting CD4+ and CD8+ T cell responses against a latent virus infection to control tumor progression and induce epitope spreading against a tumor-specific antigen19. This evidence concerns the gene CD8A and neoplasm.